Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J RENARD

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Nano Letters|November 25, 2015
Electrical Control of g-Factor in a Few-Hole Silicon Nanowire MOSFETB Voisin, R Maurand, S Barraud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data CenterJ B Vermorken, S Gundersen, M Clavel, et al.
Urology Case Reports|January 22, 2016
Can Dopamine Depletion at DAT Scan in a Non Parkinson Patient be the Cause a Refractory Overactive Bladder?J Renard, M Citeri, L Zanollo, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Phase II study of TCNU in advanced breast cancerP Dombernowsky, M Clavel, J F Smyth, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapyM Clavel, S Monfardini, S Gundersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Phase II study of iproplatin in advanced ovarian carcinomaC Sessa, J Vermorken, J Renard, et al.
Environmental Science & Technology|September 22, 2005
Use of in situ-generated dimethyldioxirane for inactivation of biological agentsWilliam H Wallace, Karen E Bushway, Susan D Miller, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|May 1, 1988
[Serum IFN induced by inactivated JEV vaccine and the protective effect of transferred immune spleen cells in mice]K Kushimoto, T Kusaba, K Nagasawa, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanomaP Alberto, M Rozencweig, M Clavel, et al.
Investigational New Drugs|July 1, 1989
A phase II study of spirogermanium in patients with advanced malignant lymphomaC Sessa, W ten Bokkel Huinik, M Clavel, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Nano Letters|November 25, 2015
Electrical Control of g-Factor in a Few-Hole Silicon Nanowire MOSFETB Voisin, R Maurand, S Barraud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data CenterJ B Vermorken, S Gundersen, M Clavel, et al.
Urology Case Reports|January 22, 2016
Can Dopamine Depletion at DAT Scan in a Non Parkinson Patient be the Cause a Refractory Overactive Bladder?J Renard, M Citeri, L Zanollo, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Phase II study of TCNU in advanced breast cancerP Dombernowsky, M Clavel, J F Smyth, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapyM Clavel, S Monfardini, S Gundersen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Phase II study of iproplatin in advanced ovarian carcinomaC Sessa, J Vermorken, J Renard, et al.
Environmental Science & Technology|September 22, 2005
Use of in situ-generated dimethyldioxirane for inactivation of biological agentsWilliam H Wallace, Karen E Bushway, Susan D Miller, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|May 1, 1988
[Serum IFN induced by inactivated JEV vaccine and the protective effect of transferred immune spleen cells in mice]K Kushimoto, T Kusaba, K Nagasawa, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanomaP Alberto, M Rozencweig, M Clavel, et al.
Investigational New Drugs|July 1, 1989
A phase II study of spirogermanium in patients with advanced malignant lymphomaC Sessa, W ten Bokkel Huinik, M Clavel, et al.
Pageof 10